In various cancers, STAT3 is often persistently activated, contributing to tumor cell proliferation, survival, angiogenesis, metastasis, and immune evasion. This makes STAT3 a promising target for anticancer therapies. The inhibition of STAT3 could theoretically halt the growth of cancer cells, induce apoptosis, and enhance the immune response against tumors.
